Loading...
VEEV logo

Veeva Systems Inc.NYSE:VEEV Stok Raporu

Piyasa Değeri US$25.5b
Hisse Fiyatı
US$171.60
US$264.46
35.1% değerinin altında içsel indirim
1Y-27.4%
7D6.5%
Portföy Değeri
Görünüm

Veeva Systems Inc.

NYSE:VEEV Stok Raporu

Piyasa değeri: US$25.5b

Veeva Systems (VEEV) Hisse Özeti

Veeva Systems Inc. Kuzey Amerika, Avrupa, Asya Pasifik, Orta Doğu, Afrika ve Latin Amerika'da yaşam bilimleri endüstrisi için bulut tabanlı yazılım sağlamaktadır. Daha fazla detay

VEEV Community Fair Values

Create Narrative

See what 166 others think this stock is worth. Follow their fair value or set your own to get alerts.

Veeva Systems Inc. Rakipler

Fiyat Geçmişi ve Performans

Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti Veeva Systems
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$171.60
52 Haftanın En Yüksek SeviyesiUS$310.50
52 Haftanın En Düşük SeviyesiUS$148.05
Beta1.1
1 Aylık Değişim-0.66%
3 Aylık Değişim-15.85%
1 Yıllık Değişim-27.44%
3 Yıllık Değişim-4.19%
5 Yıllık Değişim-33.99%
Halka arzdan bu yana değişim361.79%

Son Haberler & Güncellemeler

VEEV: AI Moat And Subscription Resilience Will Support Premium Multiple

Analysts have trimmed the Veeva Systems price target slightly, with the model fair value moving from about $270.93 to $264.46, as modestly lower assumed future P/E multiples more than offset largely unchanged growth and margin expectations. Analyst Commentary Recent Street research around Veeva Systems shows a split view, with many firms trimming price targets while still pointing to solid execution and specific areas of uncertainty that could influence the valuation over time.

VEEV: AI And Subscription Resilience Will Support Premium Software Multiple

Analysts trimmed the blended Veeva Systems price target by aligning with sector wide software multiple compression, even as they point to strong Q4 execution, resilient subscription growth, and an emerging AI and product pipeline as key longer term supports. Analyst Commentary Recent Street research around Veeva Systems reflects a mix of optimism on execution and growth, alongside more cautious views on competitive risk, AI impact, and valuation.

Veeva Systems: Growth Has More Legs Now

Apr 07

VEEV: AI Adoption In R&D Workflows Will Support Durable Premium Outlook

Analysts have adjusted their price targets on Veeva Systems into a roughly $190 to $317 range, generally trimming prior targets by tens of dollars as software valuation multiples compress, even after what they describe as solid Q4 results and broadly constructive longer term fundamentals. Analyst Commentary Recent research paints a mixed but generally constructive picture for Veeva Systems, with most firms trimming price targets while still pointing to solid execution and durable fundamentals.

Recent updates

VEEV: AI Moat And Subscription Resilience Will Support Premium Multiple

Analysts have trimmed the Veeva Systems price target slightly, with the model fair value moving from about $270.93 to $264.46, as modestly lower assumed future P/E multiples more than offset largely unchanged growth and margin expectations. Analyst Commentary Recent Street research around Veeva Systems shows a split view, with many firms trimming price targets while still pointing to solid execution and specific areas of uncertainty that could influence the valuation over time.

VEEV: AI And Subscription Resilience Will Support Premium Software Multiple

Analysts trimmed the blended Veeva Systems price target by aligning with sector wide software multiple compression, even as they point to strong Q4 execution, resilient subscription growth, and an emerging AI and product pipeline as key longer term supports. Analyst Commentary Recent Street research around Veeva Systems reflects a mix of optimism on execution and growth, alongside more cautious views on competitive risk, AI impact, and valuation.

Veeva Systems: Growth Has More Legs Now

Apr 07

VEEV: AI Adoption In R&D Workflows Will Support Durable Premium Outlook

Analysts have adjusted their price targets on Veeva Systems into a roughly $190 to $317 range, generally trimming prior targets by tens of dollars as software valuation multiples compress, even after what they describe as solid Q4 results and broadly constructive longer term fundamentals. Analyst Commentary Recent research paints a mixed but generally constructive picture for Veeva Systems, with most firms trimming price targets while still pointing to solid execution and durable fundamentals.

VEEV: AI Adoption And CRM Commitments Will Support Durable Premium Outlook

We are trimming our Veeva Systems fair value estimate to $270.93 from $302.60, as analysts broadly reset price targets in response to sector wide software multiple compression and slightly more measured assumptions for revenue growth, margins, and future P/E multiples, despite generally solid Q4 results and guidance. Analyst Commentary Street research on Veeva Systems has become more mixed, with many firms cutting price targets while still acknowledging solid Q4 execution and robust profitability.

VEEV: AI Execution And CRM Stability Will Support Durable Premium Outlook

Our fair value estimate for Veeva Systems has edged down from $308.63 to $302.60. This reflects a series of reduced Street price targets as analysts weigh maturing products, competitive pressures, software sentiment, and the balance of growth opportunities against current valuation.

VEEV: Roche Commitment And CRM Retention Will Support Durable Premium Outlook

Our analyst fair value estimate for Veeva Systems has been trimmed slightly to $308.63. This reflects a modest reset in Street price targets as analysts balance concerns about slower growth in maturing products and competitive pressure with ongoing strengths in areas like Crossix, AI adoption, and large CRM wins such as Roche.

Rising Life Sciences Cloud Standardization And AI Adoption Will Support Strong Long Term Upside

Catalysts About Veeva Systems Veeva Systems provides cloud based software, data and consulting services to life sciences companies across commercial, R&D and manufacturing functions. What are the underlying business or industry changes driving this perspective?

VEEV: Roche Rollout And CRM Retention Will Support Durable Premium Outlook

The analyst price target embedded in our Veeva Systems model edges slightly lower to about US$310 from roughly US$311. This reflects a blend of more cautious views on growth and competitive pressure, along with offsetting positive views on durable margins, CRM customer retention, and newer areas such as Crossix and early AI traction.

VEEV: Roche Expansion And CRM Migrations Will Support Durable Premium Outlook

Analysts have trimmed their fair value estimate for Veeva Systems by about US$1 to US$310.98, reflecting modest adjustments to discount rate and growth assumptions while still pointing to what they see as durable growth drivers such as pharma CRM migrations, broader Vault adoption and newer areas like Crossix and AI. Analyst Commentary Recent Street research on Veeva Systems reflects a mix of optimism and caution, with differing views clustering around the durability of growth in CRM and Vault, the timing of pharma migrations, and how current valuation stacks up against execution and contract wins.

VEEV: Roche Commitment And CRM Migrations Will Likely Sustain Premium Outlook

Analysts have modestly trimmed their blended price target for Veeva Systems to about $312 from roughly $321, reflecting a slightly higher discount rate and lower implied future multiple, even as they highlight accelerating CRM migrations, including Roche's global Vault CRM rollout, and improving long term growth and margin expectations. Analyst Commentary Street research remains broadly constructive on Veeva Systems, with recent target changes reflecting a recalibration of software multiples rather than a material shift in company specific fundamentals.

Veeva Systems' (NYSE:VEEV) Performance Is Even Better Than Its Earnings Suggest

Dec 03
Veeva Systems' (NYSE:VEEV) Performance Is Even Better Than Its Earnings Suggest

VEEV: Continued Momentum And New Commitments Will Likely Sustain Premium Outlook

Analysts have significantly raised their price targets on Veeva Systems, with recent updates moving targets as high as $380. They cite the company's strong sales growth prospects and solid momentum, driven by accelerating CRM customer commitments and new partnerships.

Pharma Wins And New Partnerships Will Drive Cloud Momentum In Coming Quarters

Veeva Systems' analyst price target saw a significant increase, rising by more than $80 to reflect higher expectations for sales growth and ongoing customer commitments. Analysts cited the company’s strengthening position in CRM and positive momentum across key pharma relationships.

IQVIA Resolution And Embedded AI Will Expand Digital Healthcare Cloud

Narrative Update on Veeva Systems: Analyst Price Target Revision Analysts have raised their fair value estimate for Veeva Systems to approximately $321 per share, up by nearly $4. They cited stronger than expected sales momentum, driven by new major customer commitments and continued growth in key business segments.

Data Cloud Expansion And AI Efficiencies Will Drive Future Success

Analysts have raised their price target for Veeva Systems to $314.71, citing strong Q2 “beat and raise” results, momentum in both Commercial and R&D segments, successful Vault CRM rollouts with major pharma clients, and ongoing market share gains in life sciences CRM. Analyst Commentary Bullish analysts highlighted Veeva's strong “beat and raise” Q2 results, with both subscription and services revenues growing solidly year-over-year, driven by performance in both Commercial and R&D technology segments.

If EPS Growth Is Important To You, Veeva Systems (NYSE:VEEV) Presents An Opportunity

Jul 11
If EPS Growth Is Important To You, Veeva Systems (NYSE:VEEV) Presents An Opportunity

Veeva Systems (VEEV) Earnings Beat And AI Ambitions Shift The Investment Case

May 30
Veeva Systems (VEEV) Earnings Beat And AI Ambitions Shift The Investment Case

Veeva Systems: Substantially Overvalued As Growth Slows

Apr 17

Veeva Systems: Staying Buy Rated As VEEV Is Executing Well

Mar 19

Veeva Systems: Solid Q4 With Margin Expansion

Mar 07

Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising

Jan 28

Veeva Systems Q3: Making Progress With Vault CRM; Reiterating 'Strong Buy'

Dec 06

Veeva Systems: Too Much Needs To Go Right, For Bull Case

Oct 08

Veeva Systems: SMB Sector Is Growing Momentum

Sep 24

Veeva: Q2, Robust Dev Cloud Growth, While Commercial Cloud Picks Up Steam

Aug 30
User avatar

Expanding Clinical And CRM Frontiers Boosts Market Share And Revenue Prospects

Expansion in clinical operations and CRM offerings strengthens Veeva's competitive position and promises higher recurring revenue through customer confidence and adoption.

Veeva Systems: Optimism Ahead Of Q2 Earnings Release

Aug 24

Veeva Systems: Blend Of Value, Growth, And High Quality

Jul 29

Hissedar Getirileri

VEEVUS Healthcare ServicesUS Pazar
7D6.5%2.7%0.8%
1Y-27.4%-37.4%27.7%

Getiri vs. Endüstri: VEEV geçen yıl % -37.4 oranında getiri sağlayan US Healthcare Services sektörünü aştı.

Getiri vs Piyasa: VEEV geçen yıl % 27.7 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is VEEV's price volatile compared to industry and market?
VEEV volatility
VEEV Average Weekly Movement6.2%
Healthcare Services Industry Average Movement10.7%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.3%

İstikrarlı Hisse Senedi Fiyatı: VEEV son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: VEEV 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
20077,928Peter Gassnerwww.veeva.com

Veeva Systems Inc. Kuzey Amerika, Avrupa, Asya Pasifik, Orta Doğu, Afrika ve Latin Amerika'da yaşam bilimleri endüstrisi için bulut tabanlı yazılımlar sağlamaktadır. Şirket, ilaç ve biyoteknoloji şirketleri için Veeva Vault CRM Suite'i içeren Veeva Commercial Cloud; birden fazla kanal ve coğrafyada tıbbi içerik kaynağı sağlayan Veeva Medical; uçtan uca bir içerik ve dijital varlık yönetimi çözümü olan Veeva PromoMats ve ilaç markaları için bir analiz platformu olan Veeva Crossix'i sunmaktadır. Ayrıca, bir müşteri referans veri çözümü olan Veeva OpenData; derin veri sağlayan Veeva Link; kimliksizleştirilmiş ve uzunlamasına hasta verilerini içeren Veeva Compass ve erişim ve çok kanallı etkileşim ölçümleri sağlayan Veeva CRM Pulse gibi Veeva Data Cloud'u da sunmaktadır.

Veeva Systems Inc. Temel Bilgiler Özeti

Veeva Systems'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
VEEV temel i̇stati̇sti̇kler
Piyasa değeriUS$25.47b
Kazançlar(TTM)US$908.91m
Gelir(TTM)US$3.20b
30.8x
F/K Oranı
8.8x
P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
VEEV gelir tablosu (TTM)
GelirUS$3.20b
Gelir MaliyetiUS$782.02m
Brüt KârUS$2.41b
Diğer GiderlerUS$1.50b
KazançlarUS$908.91m

Son Raporlanan Kazançlar

Jan 31, 2026

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)5.56
Brüt Marj75.53%
Net Kâr Marjı28.44%
Borç/Özkaynak Oranı0%

VEEV uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/01 11:42
Gün Sonu Hisse Fiyatı2026/05/01 00:00
Kazançlar2026/01/31
Yıllık Kazançlar2026/01/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Veeva Systems Inc. 45 Bu analistlerden 28, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Joseph VruwinkBaird
Saket KaliaBarclays
Sean DodgeBMO Capital Markets Equity Research